False negative tests in breast cancer may lead to wrong drug choice, study finds
Monday, June 27, 2011 - 21:30
in Health & Medicine
A team of researchers has confirmed that between 10 and 20 percent of breast cancers classified as estrogen receptor negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer.